Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

ABT, BSX, MDT
Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

LONDON, April 2, 2013 /PRNewswire/ --

Medical appliances & equipment makers have been critical of President Obama's Affordable Care Act (ACA). Under the healthcare reform, medical appliances & equipment makers such as Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM) are required to pay a 2.3% excise tax on U.S. sales. The industry has been lobbying to repeal the 2.3% tax on U.S. sales, saying that it would lead to higher costs and hamper research and development activities. Medical appliances & equipment makers ended mostly lower on Monday, tracking losses in the broad market. StockCall has posted free technical research reports on BSX, ABT, MDT, ZMH, and ETRM and these can be accessed by signing up at

http://www.stockcall.com/analysis

Shares of Boston Scientific Corporation touched a 52-week high of $7.86 yesterday, however, the stock failed to hold on to its gains. It closed 0.13% lower at $7.80 on above average volume of 29.66 million. Boston Scientific shares have gained more than 4.80% in the last three trading sessions. The stock has outperformed the broad market so far in 2013, gaining more than 36%. Its MACD has just crossed above the signal line, which is a strong bullish signal. Download the free report on BSX upon registration at

http://www.StockCall.com/BSX040213.pdf

Abbott Laboratories shares ended nearly flat in Monday's trading session. The stock fell to an intra-day low of $34.95 before paring most of its losses to finish the day 0.03% lower at $35.31 on volume of 6.03 million. The stock has gained nearly 2.80% in the last three sessions. Abbott's shares recently broke through $35 resistance level, which is a strong bullish signal. The positive trend is further confirmed by the stock's MACD chart. The company's shares are also trading above their 50-day and 200-day moving averages. ABT technical report can be accessed for free by signing up at

http://www.StockCall.com/ABT040213.pdf

Medtronic Inc.'s shares edged lower on Monday; however, the losses were limited. The stock closed 0.34% lower at $46.80 on volume of 2.81 million. The company's shares are currently trading close to their 52-week high of $47.40. The stock has outperformed the broad market in 2013, gaining more than 14%. Its shares are currently facing resistance at around $47. The stock's MACD is currently trading above the signal line and the zero-line, which is a bullish signal. The free report on MDT can be downloaded by signing up now at

http://www.StockCall.com/MDT040213.pdf

Zimmer Holdings Inc.'s shares ended marginally lower yesterday. The stock ended the day 0.12% lower at $75.13 on volume of 693,613. Its shares are currently hovering around their 52-week high of $76.75. The stock saw a series of highs last week, which is a bullish signal. The upbeat trend is further confirmed by recent volume activity and the stock's MACD chart. Free report on ZMH can be accessed by registering at

http://www.StockCall.com/ZMH040213.pdf

EnteroMedics Inc.'s shares rose sharply on Monday even as the broad market struggled. The stock closed 1% higher at $1.01 on volume of 776,418. EnteroMedics' shares touched an intra-day high of $1.04 yesterday. Despite the gains, the stock is down nearly 1% in the last three trading sessions. Shares of ETRM are currently trading well below their 50-day and 200-day moving averages. Register with StockCall and download the research on ETRM for free at

http://www.StockCall.com/ETRM040213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today